Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm - PubMed (original) (raw)
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm
E L von Rüden et al. Neurobiol Dis. 2015 Jan.
Abstract
The endocannabinoid system serves as a retrograde negative feedback mechanism. It is thought to control neuronal activity in an epileptic neuronal network. The purpose of this study was to evaluate the impact of the endocannabinoid and endovanilloid systems on both epileptogenesis and ictogenesis. Therefore, we modulated the endocannabinoid and endovanilloid systems genetically and pharmacologically, and analyzed the subsequent impact on seizure progression in the kindling model of temporal lobe epilepsy in mice. In addition, the impact of seizures on associated cellular alterations was evaluated. Our principal results revealed that the endocannabinoid system affects seizure and afterdischarge duration dependent on the neuronal subpopulation being modulated. Genetic deletion of CB1-receptors (CB1Rs) from principal neurons of the forebrain and pharmacological antagonism with rimonabant (5 mg/kg) caused longer seizure duration. Deletion of CB1R from GABAergic forebrain neurons resulted in the opposite effect. Along with these findings, the CB1R density was elevated in animals with repetitively induced seizures. However, neither genetic nor pharmacological interventions had any impact on the development of generalized seizures. Other than CB1, genetic deletion or pharmacological blockade with SB366791 (1 mg/kg) of transient receptor potential vanilloid receptor 1 (TRPV1) had no effect on the duration of behavioral or electrographic seizure activity in the kindling model. In conclusion, we demonstrate that endocannabinoid, but not endovanilloid, signaling affects termination of seizure activity, without influencing seizure severity over time. These effects are dependent on the neuronal subpopulation. Thus, the data argue that the endocannabinoid system plays an active role in seizure termination but does not regulate epileptogenesis.
Keywords: Amygdala; CB1; Endovanilloid; GABA; Glutamate; Hyperexcitable network; Ictogenesis; Neurogenesis; Seizure; TRPV1.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
von Rüden EL, Bogdanovic RM, Wotjak CT, Potschka H. von Rüden EL, et al. Neurobiol Dis. 2015 May;77:238-45. doi: 10.1016/j.nbd.2015.03.016. Epub 2015 Mar 18. Neurobiol Dis. 2015. PMID: 25796567 - Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V. Micale V, et al. Neurobiol Dis. 2009 Oct;36(1):70-80. doi: 10.1016/j.nbd.2009.06.015. Epub 2009 Jul 8. Neurobiol Dis. 2009. PMID: 19591935 - Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
Wendt H, Soerensen J, Wotjak CT, Potschka H. Wendt H, et al. Epilepsia. 2011 Jul;52(7):e62-5. doi: 10.1111/j.1528-1167.2011.03079.x. Epub 2011 May 31. Epilepsia. 2011. PMID: 21627644 - Kindling model of epilepsy.
McNamara JO. McNamara JO. Adv Neurol. 1986;44:303-18. Adv Neurol. 1986. PMID: 2871721 Review. - [Molecular mechanism underlying epileptic seizure: forwards development of novel drugs for untreatable epilepsy].
Omori K, Inagaki C, Sasa M. Omori K, et al. Nihon Yakurigaku Zasshi. 1999 Sep;114(3):161-8. doi: 10.1254/fpj.114.161. Nihon Yakurigaku Zasshi. 1999. PMID: 10553579 Review. Japanese.
Cited by
- Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.
Lourenço DM, Ribeiro-Rodrigues L, Sebastião AM, Diógenes MJ, Xapelli S. Lourenço DM, et al. Int J Mol Sci. 2020 Oct 3;21(19):7309. doi: 10.3390/ijms21197309. Int J Mol Sci. 2020. PMID: 33022963 Free PMC article. Review. - TRPV1 Channel: A Potential Drug Target for Treating Epilepsy.
Nazıroğlu M. Nazıroğlu M. Curr Neuropharmacol. 2015;13(2):239-47. doi: 10.2174/1570159x13666150216222543. Curr Neuropharmacol. 2015. PMID: 26411767 Free PMC article. Review. - Linking kindling to increased glutamate release in the dentate gyrus of the hippocampus through the STXBP5/tomosyn-1 gene.
Batten SR, Matveeva EA, Whiteheart SW, Vanaman TC, Gerhardt GA, Slevin JT. Batten SR, et al. Brain Behav. 2017 Aug 13;7(9):e00795. doi: 10.1002/brb3.795. eCollection 2017 Sep. Brain Behav. 2017. PMID: 28948088 Free PMC article. - Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.
Freundt-Revilla J, Kegler K, Baumgärtner W, Tipold A. Freundt-Revilla J, et al. PLoS One. 2017 Jul 10;12(7):e0181064. doi: 10.1371/journal.pone.0181064. eCollection 2017. PLoS One. 2017. PMID: 28700706 Free PMC article. - Molecular Targets of Cannabidiol in Neurological Disorders.
Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Ibeas Bih C, et al. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases